CBD Chewing Gum: Promising Concept, Thin Evidence
CBD chewing gum drug delivery is a promising concept with limited clinical evidence. Research gaps remain in absorption mechanisms, dosing precision, and long-term safety. Current trials show no significant efficacy over placebo.
Cannabis Oil Did Not Meaningfully Reduce Pain in Nerve-Injury Patients, Rigorous Trial Finds
Our study findings indicate that cannabis-based medicine did not improve pain by a clinically important margin. Consequently, our study advises against the addition of cannabis-based medicine to the standard medication treatment for pain in patients with…
Expert Commentary on Cannabis Trial for Brachial Plexus Pain
This expert commentary reviews a cannabis brachial plexus neuropathic pain trial showing no significant benefit. The findings help guide clinicians in managing expectations. Continued research into neuropathic pain mechanisms remains essential.
Cannabinoid Clinical Trials: CBD Compared to Placebo in Fibromyalgia
This article reviews cannabinoid clinical trials fibromyalgia focusing on CBD versus placebo. The trial found no superiority of CBD over placebo in reducing fibromyalgia pain. These findings inform clinicians and patients about CBD's role in fibromyalgia…
`Cannabinoids for PTSD and Substance Use: Clinical Evidence`
Clinical Takeaway Trauma-focused treatments remain effective for PTSD even in patients who use cannabis, including those with co-occurring substance use disorders. Cannabis use at baseline does not appear to undermine the clinical benefits of…
Endocannabinoid System Research: Cannabis & PTSD Treatment
This PTSD cannabis trauma meta-analysis examines how cannabis use affects trauma-focused treatments for co-occurring PTSD and substance use disorders. Findings show cannabis does not significantly undermine evidence-based PTSD interventions. This…
Trauma-Focused Treatment and Cannabis Use in PTSD Care
Trauma-focused treatment PTSD cannabis use remains effective even with co-occurring substance use disorders. Cannabis use does not reduce the benefits of trauma-focused psychotherapy. This insight supports maintaining evidence-based PTSD care protocols.
